A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With ST Segment Elevation Myocardial Infarction (STEMI)

Clinical trial NCT01770613 · WITHDRAWN

Trial details

NCT number: NCT01770613
Sponsor: Stemedica Cell Technologies, Inc.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

ST Segment Elevation Myocardial Infarction (STEMI)Allogeneic Mesenchymal Bone Marrow Cells

Start date: 2013-02-01
Primary completion: 2016-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.